+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID06396533

Improving Pre-Surgical Detection of Muscle Invasive Bladder Tumors Using Combined Diagnostic Tests Prior to Planned Cystectomy

Led by Fox Chase Cancer Center · Updated on 2026-11-02

92

Participants Needed

2

Research Sites

96 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are investigating a combined diagnostic approach to better predict the presence of residual muscle invasive tumors in patients scheduled for bladder removal surgery cystectomy due to bladder cancer. The study focuses on evaluating a panel that includes systematic endoscopic evaluation SEE, a blood-based circulating tumor DNA ctDNA assay, and a urine-based cell-free DNA cfDNA assay. The main goal is to determine the accuracy of these tests in identifying muscle invasive bladder cancer before surgery. Participants include patients planned for radical cystectomy due to various forms of high-grade urothelial carcinoma, including non-muscle invasive but high-risk cases and muscle invasive tumors, regardless of neoadjuvant chemotherapy receipt. Before surgery, tissue from bladder tumors is collected along with blood and urine samples for biomarker testing. During surgery, additional bladder biopsies and sample collections are performed. After cystectomy, the test results are compared to the final pathology of the removed tissue. Blood samples continue to be collected at multiple time points after surgery for ongoing biomarker analysis and surveillance. Participants will undergo baseline assessments including tissue, urine, and blood sample collections, rigid cystoscopy with biopsies during surgery, and follow-up blood draws at 4-6 weeks and 6 months post-surgery, with optional collections at 12 and 24 months. The study measures include the accuracy of urine and blood biomarker tests in detecting muscle invasive disease and their predictive value compared to surgical specimens. This observational study involves no experimental treatment and monitors patients through sample collections and clinical evaluations over up to two years.

CONDITIONS

Brief Title

Increasing Pre-Surgical Identification of Muscle Invasive Tumor Evaluations Prior to Planned Cystectomy (INSITE)

Research Team

A

Alexander Kutikov, M.D.

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here